Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2021 | 2 |
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Differences in JAK Isoform Selectivity Among Different Types of JAK Inhibitors Evaluated for Rheumatic Diseases Through In Vitro Profiling.
Arthritis Rheumatol. 2023 Nov;75(11):2054-2061. doi: 10.1002/art.42547. Epub 2023 Aug 3.
Arthritis Rheumatol. 2023.
PMID: 37134144
Identification of Novel Small Molecule Ligands for JAK2 Pseudokinase Domain.
Virtanen AT, Haikarainen T, Sampathkumar P, Palmroth M, Liukkonen S, Liu J, Nekhotiaeva N, Hubbard SR, Silvennoinen O.
Virtanen AT, et al. Among authors: palmroth m.
Pharmaceuticals (Basel). 2023 Jan 4;16(1):75. doi: 10.3390/ph16010075.
Pharmaceuticals (Basel). 2023.
PMID: 36678572
Free PMC article.
Item in Clipboard
Tofacitinib treatment modulates the levels of several inflammation-related plasma proteins in rheumatoid arthritis and baseline levels of soluble biomarkers associate with the treatment response.
Valli A, Kuuliala K, Virtanen A, Kuuliala A, Palmroth M, Peltomaa R, Vidqvist KL, Leirisalo-Repo M, Silvennoinen O, Isomäki P.
Valli A, et al. Among authors: palmroth m.
Clin Exp Immunol. 2022 Dec 15;210(2):141-150. doi: 10.1093/cei/uxac085.
Clin Exp Immunol. 2022.
PMID: 36124688
Free PMC article.
Item in Clipboard
Tofacitinib Suppresses Several JAK-STAT Pathways in Rheumatoid Arthritis In Vivo and Baseline Signaling Profile Associates With Treatment Response.
Palmroth M, Kuuliala K, Peltomaa R, Virtanen A, Kuuliala A, Kurttila A, Kinnunen A, Leirisalo-Repo M, Silvennoinen O, Isomäki P.
Palmroth M, et al.
Front Immunol. 2021 Sep 24;12:738481. doi: 10.3389/fimmu.2021.738481. eCollection 2021.
Front Immunol. 2021.
PMID: 34630419
Free PMC article.
Item in Clipboard
IRF2BP2 Mutation Is Associated with Increased STAT1 and STAT5 Activation in Two Family Members with Inflammatory Conditions and Lymphopenia.
Palmroth M, Viskari H, Seppänen MRJ, Keskitalo S, Virtanen A, Varjosalo M, Silvennoinen O, Isomäki P.
Palmroth M, et al.
Pharmaceuticals (Basel). 2021 Aug 13;14(8):797. doi: 10.3390/ph14080797.
Pharmaceuticals (Basel). 2021.
PMID: 34451894
Free PMC article.
Item in Clipboard
Development of Versatile Human In Vitro Vascularized Adipose Tissue Model with Serum-Free Angiogenesis and Natural Adipogenesis Induction.
Huttala O, Palmroth M, Hemminki P, Toimela T, Heinonen T, Ylikomi T, Sarkanen JR.
Huttala O, et al. Among authors: palmroth m.
Basic Clin Pharmacol Toxicol. 2018 Sep;123 Suppl 5:62-71. doi: 10.1111/bcpt.12987. Epub 2018 Apr 27.
Basic Clin Pharmacol Toxicol. 2018.
PMID: 29443452
Free article.
Item in Clipboard
Cite
Cite